254 related articles for article (PubMed ID: 25375378)
21. The significance of ubiquitin proteasome pathway in cancer development.
Yerlikaya A; Yöntem M
Recent Pat Anticancer Drug Discov; 2013 Sep; 8(3):298-309. PubMed ID: 23061719
[TBL] [Abstract][Full Text] [Related]
22. Suppression of centrosome protein TACC3 induces G1 arrest and cell death through activation of p38-p53-p21 stress signaling pathway.
Suhail TV; Singh P; Manna TK
Eur J Cell Biol; 2015 Feb; 94(2):90-100. PubMed ID: 25613365
[TBL] [Abstract][Full Text] [Related]
23. Waste disposal-An attractive strategy for cancer therapy.
Salami J; Crews CM
Science; 2017 Mar; 355(6330):1163-1167. PubMed ID: 28302825
[TBL] [Abstract][Full Text] [Related]
24. Regulating the ARNT/TACC3 axis: multiple approaches to manipulating protein/protein interactions with small molecules.
Guo Y; Partch CL; Key J; Card PB; Pashkov V; Patel A; Bruick RK; Wurdak H; Gardner KH
ACS Chem Biol; 2013 Mar; 8(3):626-35. PubMed ID: 23240775
[TBL] [Abstract][Full Text] [Related]
25. The Small Molecules Targeting Ubiquitin-Proteasome System for Cancer Therapy.
Ao N; Chen Q; Liu G
Comb Chem High Throughput Screen; 2017; 20(5):403-413. PubMed ID: 28699494
[TBL] [Abstract][Full Text] [Related]
26. The ubiquitin-proteasome pathway an emerging anticancer strategy for therapeutics: a patent analysis.
Jain CK; Arora S; Khanna A; Gupta M; Wadhwa G; Sharma SK
Recent Pat Anticancer Drug Discov; 2015; 10(2):201-13. PubMed ID: 25877716
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of TACC3 by a small molecule inhibitor in breast cancer.
Campo L; Breuer EK
Biochem Biophys Res Commun; 2018 Apr; 498(4):1085-1092. PubMed ID: 29555478
[TBL] [Abstract][Full Text] [Related]
28. Targeted protein degradation and the enzymology of degraders.
Fisher SL; Phillips AJ
Curr Opin Chem Biol; 2018 Jun; 44():47-55. PubMed ID: 29885948
[TBL] [Abstract][Full Text] [Related]
29. Small molecules destabilize cIAP1 by activating auto-ubiquitylation.
Sekine K; Takubo K; Kikuchi R; Nishimoto M; Kitagawa M; Abe F; Nishikawa K; Tsuruo T; Naito M
J Biol Chem; 2008 Apr; 283(14):8961-8. PubMed ID: 18230607
[TBL] [Abstract][Full Text] [Related]
30. Protein degradation: Prime time for PROTACs.
Deshaies RJ
Nat Chem Biol; 2015 Sep; 11(9):634-5. PubMed ID: 26284668
[No Abstract] [Full Text] [Related]
31. Lessons in PROTAC Design from Selective Degradation with a Promiscuous Warhead.
Bondeson DP; Smith BE; Burslem GM; Buhimschi AD; Hines J; Jaime-Figueroa S; Wang J; Hamman BD; Ishchenko A; Crews CM
Cell Chem Biol; 2018 Jan; 25(1):78-87.e5. PubMed ID: 29129718
[TBL] [Abstract][Full Text] [Related]
32. TACC3 promotes stemness and is a potential therapeutic target in hepatocellular carcinoma.
Zhou DS; Wang HB; Zhou ZG; Zhang YJ; Zhong Q; Xu L; Huang YH; Yeung SC; Chen MS; Zeng MS
Oncotarget; 2015 Sep; 6(27):24163-77. PubMed ID: 26219398
[TBL] [Abstract][Full Text] [Related]
33. TACC3 promotes prostate cancer cell proliferation and restrains primary cilium formation.
Qie Y; Wang L; Du E; Chen S; Lu C; Ding N; Yang K; Xu Y
Exp Cell Res; 2020 May; 390(2):111952. PubMed ID: 32156598
[TBL] [Abstract][Full Text] [Related]
34. Kip1 degradation via the ubiquitin-proteasome pathway.
Tam SW; Theodoras AM; Pagano M
Leukemia; 1997 Apr; 11 Suppl 3():363-6. PubMed ID: 9209391
[TBL] [Abstract][Full Text] [Related]
35. Small-molecule control of intracellular protein levels through modulation of the ubiquitin proteasome system.
Buckley DL; Crews CM
Angew Chem Int Ed Engl; 2014 Feb; 53(9):2312-30. PubMed ID: 24459094
[TBL] [Abstract][Full Text] [Related]
36. Protein knockdown using methyl bestatin-ligand hybrid molecules: design and synthesis of inducers of ubiquitination-mediated degradation of cellular retinoic acid-binding proteins.
Itoh Y; Ishikawa M; Naito M; Hashimoto Y
J Am Chem Soc; 2010 Apr; 132(16):5820-6. PubMed ID: 20369832
[TBL] [Abstract][Full Text] [Related]
37. The C-terminus of MIP-T3 protein is required for ubiquitin-proteasome-mediated degradation in human cells.
Guo CW; Liu G; Xiong S; Ge F; Fuse T; Wang YF; Kitazato K
FEBS Lett; 2011 May; 585(9):1350-6. PubMed ID: 21510943
[TBL] [Abstract][Full Text] [Related]
38. REGgamma proteasome mediates degradation of the ubiquitin ligase Smurf1.
Nie J; Wu M; Wang J; Xing G; He F; Zhang L
FEBS Lett; 2010 Jul; 584(14):3021-7. PubMed ID: 20580715
[TBL] [Abstract][Full Text] [Related]
39. TACC3 depletion sensitizes to paclitaxel-induced cell death and overrides p21WAF-mediated cell cycle arrest.
Schneider L; Essmann F; Kletke A; Rio P; Hanenberg H; Schulze-Osthoff K; Nürnberg B; Piekorz RP
Oncogene; 2008 Jan; 27(1):116-25. PubMed ID: 17599038
[TBL] [Abstract][Full Text] [Related]
40. Targeting the ubiquitin E1 as a novel anti-cancer strategy.
Xu W; Lukkarila JL; da Silva SR; Paiva SL; Gunning PT; Schimmer AD
Curr Pharm Des; 2013; 19(18):3201-9. PubMed ID: 23151135
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
